Portage Biotech Inc. (ATON)
NASDAQ · Financial Services
Portage Biotech Inc. Operating Income 2024–2025
Portage Biotech Inc. annual/quarterly operating income history and growth rate from 2024 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Portage Biotech Inc. operating income for the quarter ending September 30, 2025 was -4.5 M, a 179.52% increase year-over-year.
- Portage Biotech Inc. operating income for the twelve months ending September 30, 2025 was -12.2 M.
- Portage Biotech Inc. annual operating income for 2025 was -7.4 M, a 59.36% decrease from 2024.
- Portage Biotech Inc. annual operating income for 2024 was -18.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Portage Biotech Inc. Operating Income — FAQ
Portage Biotech Inc. (ATON) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Portage Biotech Inc.'s operating income?
Portage Biotech Inc. (ATON) reported operating income of -$7M for fiscal 2025.
Where can I see ATON's operating income history?
The chart and table above show Portage Biotech Inc.'s operating income by year and by quarter, including the growth rate.